Literature DB >> 16259377

Effects of magnesium sulfate on spinal cord tissue lactate and malondialdehyde levels after spinal cord trauma.

M Ozdemir1, Sahika Liva Cengiz, M Gürbilek, T C Oğün, M E Ustün.   

Abstract

OBJECTIVE: In the present study, the effects of magnesium sulfate (MgSO4) on tissue lactate and malondialdehyde (MDA) levels after spinal cord trauma (SCT) in rabbits were studied.
SUBJECTS: Thirty New Zeland rabbits. Interventions. The rabbits were divided equally into three groups: group I was the sham- operated group, group II suffered from SCT but received no treatment, group III was given a dose of 100 mg/kg of magnesium sulfate intravenously at 5th minute after SCT. MEASUREMENTS. The lactate and MDA levels were measured in contused spinal cord tissue at 60 minutes after SCT. There was a significant increase of lactate and MDA levels in group II (p < 0.05) when compared with groups I and III, and a significant increase in the level of MDA in group III compared with group I, and also a significant decrease compared with group II, which was the trauma group without treatment (p < 0.05).
CONCLUSION: The findings of this study showed that magnesium sulfate can attenuate the increase of tissue MDA and supply a normalization of lactate levels following SCT which may be related to the neuroprotective effects of (MgSO4).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16259377

Source DB:  PubMed          Journal:  Magnes Res        ISSN: 0953-1424            Impact factor:   1.115


  5 in total

Review 1.  A grading system to evaluate objectively the strength of pre-clinical data of acute neuroprotective therapies for clinical translation in spinal cord injury.

Authors:  Brian K Kwon; Elena B Okon; Eve Tsai; Michael S Beattie; Jacqueline C Bresnahan; David K Magnuson; Paul J Reier; Dana M McTigue; Phillip G Popovich; Andrew R Blight; Martin Oudega; James D Guest; Lynne C Weaver; Michael G Fehlings; Wolfram Tetzlaff
Journal:  J Neurotrauma       Date:  2010-10-18       Impact factor: 5.269

Review 2.  A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury.

Authors:  Brian K Kwon; Elena Okon; Jessica Hillyer; Cody Mann; Darryl Baptiste; Lynne C Weaver; Michael G Fehlings; Wolfram Tetzlaff
Journal:  J Neurotrauma       Date:  2010-04-14       Impact factor: 5.269

3.  Does dexmedetomidine reduce secondary damage after spinal cord injury? An experimental study.

Authors:  Adem Aslan; Mustafa Cemek; Olcay Eser; Korhan Altunbaş; Mehmet Emin Buyukokuroglu; Murat Cosar; Orhan Baş; Yuksel Ela; Huseyin Fidan
Journal:  Eur Spine J       Date:  2009-01-08       Impact factor: 3.134

4.  Dantrolene can reduce secondary damage after spinal cord injury.

Authors:  Adem Aslan; Mustafa Cemek; Mehmet Emin Buyukokuroglu; Korhan Altunbas; Orhan Bas; Yusuf Yurumez; Murat Cosar
Journal:  Eur Spine J       Date:  2009-05-26       Impact factor: 3.134

5.  Effects of ketamine on the balance of ions Ca2+, Mg2+, Cu2+ and Zn2+ in the ischemia-reperfusion affected spinal cord tissues in rabbits.

Authors:  Qi Jing Yu; Qing Shan Zhou; Hai Bo Huang; Yan Lin Wan; Shu Fang Tian; Dai Ming Duan
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.